Company Filing History:
3 out of 444 
3 out of 1,386 
Years Active: 2018-2023
Title: Jan Krönke: Innovator in Disease Biomarkers and Treatment Methods
Introduction
Jan Krönke is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of disease biomarkers and treatment methods. With a total of 3 patents to his name, Krönke's work has the potential to impact various therapeutic approaches.
Latest Patents
Krönke's latest patents include innovative methods related to disease biomarkers. One notable patent features a knock-in mouse comprising a mutation in an endogenous CRBN locus, along with methods of use thereof. Another patent focuses on IMiD screening methods utilizing IMiD-sensitive cells with a mutant CRBN, further showcasing his expertise in genetic research and therapeutic applications.
Career Highlights
Throughout his career, Jan Krönke has worked with esteemed organizations such as the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in the field of medicine.
Collaborations
Some of Krönke's notable coworkers include Benjamin L. Ebert and Steven A. Carr. Their collaborative efforts have further advanced the research and development of innovative treatment methods.
Conclusion
Jan Krönke's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in disease treatment and understanding.